New cationic amphiphilic compounds as potential antibacterial agents
Visser, Peter Christian de
Citation
Visser, P. C. de. (2006, February 23). New cationic amphiphilic compounds as potential
antibacterial agents. Retrieved from https://hdl.handle.net/1887/4335
Version:
Corrected Publisher’s Version
License:
Licence agreement concerning inclusion of doctoral thesis in the
Institutional Repository of the University of Leiden
Downloaded from:
https://hdl.handle.net/1887/4335
New Cationic Amphiphilic Compounds
as Potential Antibacterial Agents
PROEFSCHRIFT
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden,
op gezag van de Rector M agnificus Dr. D.D. Breim er,
hoogleraar aan de faculteit der W iskunde en
Natuurwetenschappen en die der Geneeskunde,
volgens het besluit van het College voor Prom oties
te verdedigen op donderdag 23 februari 2006
te klokke 16:15 uur
door
Pet
er Chri
st
i
an de Vi
sser
Promotiecommissie
Promotor
:
Prof. dr. H.S. Overkleeft
Co-promotor :
Dr. D. Noort (TNO Defensie & Veiligheid)
Referent
:
Dr. M. Overhand
Overige leden :
Prof. dr. J. Lugtenburg
Prof. dr. A. van der Gen
Prof. dr. G.A. van der Marel
Prof. dr. J. Brouwer
Dr. D.V. Filippov
Dr. P.A.V. van Hooft (TNO Defensie & Veiligheid)
The research described in this thesis was conducted at the Bioorganic Synthesis (BIOSYN) department of the Leiden Institute of Chemistry (LIC, Leiden University) in cooperation with and financed by TNO.
Printed by Optima Grafische Communicatie, Rotterdam, 2006
in memoriam prof. dr. Jacques H. van Boom
If we knew what it was we were doing, it would not be called research, would it?
- Albert Einstein (1879-1955)
Table of Contents
Table of Contents
List of Abbrevations
6G eneral Introduction
9Chapter 1
45Biological Evaluation of Stabilized Drosocin Analogues
Chapter 2
57Safety-Catch Synthesis & Biological Evaluation of Polymyxin B1 and Analogues
Chapter 3
75Acyl M igration in Polymyxin Synthesis
Chapter 4
89Design, Synthesis & Biological Evaluation of PM BN/CAP Conjugates
Chapter 5
103Table of Contents
Chapter 6
117Fluorous Techniques in Solid-Phase Peptide Synthesis
Chapter 7
131Summary & Future Prospects
General M aterials & M ethods
143Samenvatting
145Summary in Dutch
List of Publications
149Curriculum V itae
151List of Abbreviations
6
List of Abbreviations
a C-terminal amide AA amino acid residue1 Abu DŽ-aminobutyric acid Ac acetyl
ACPC trans-2-aminocyclopentane carboxylic acid
Ada 1-adamantaneacetyl ADP adenosine 5’-diphosphate Ala (A) alanine
AM aminomethyl anh. anhydrous aq. aqueous Ar aromatic Arg (R) arginine Asn (N) asparagine Asp (D) aspartic acid AP alkaline phosphatase ATCC American type culture
collection
Ava Dž-aminovaleric acid2
ǃAla ǃ-alanine BF2 buforin II
BHI brain/heart infusion bm broad multiplet Bn benzyl Boc tert.-butoxycarbonyl BOP (benzotriazol-1-yloxy)tris- (dimethylamino)phosphonium hexafluorophosphate Bu butyl c (prefix) cyclo
Cx n-alkyl chain containing x
carbon atoms
CAP cationic antimicrobial peptide Capro (S)-3-amino-1-carboxymethyl
caprolactame CD circular dichroism CFU colony-forming units Clt (2-chlorotriphenyl)methyl CMP cytidine 5’-monophosphate Cmpi N-carboxymethylpiperazine COSY correlated spectroscopy CPC cetylpyridinium chloride
1 W here applicable, am ino acid residues are of the L
-configuration unless otherw ise stated.
2 D ue to shortage of unique one-letter codes, Ava is
denoted w ith X in C hapter 4 and Tm d(Phe) w ith Z in C hapter 7.
CPMBN Cys-polymyxin B nonapeptide CTAB cetyltrimethylammonium
bromide Cys (C) cysteine
Dab (X) ǂ,DŽ-diaminobutyric acid2 dansyl 5-dimethylamino-1-naphthalenesulfonyl DAST diethylaminosulfurtrifluoride DCC N,N’-dicyclohexylcarbodiimide DCE 1,2-dichloroethane Dde 1-(4,4-dimethyl-2,6-dioxo- cyclohex-1-ylidene)ethyl Dhb (U) ǂ-aminodehydrobutyric acid DIAD diisoproyl azodicarboxylate DiBAl-H diisobutylaluminum hydride DIC N,N’-diisopropylcarbodiimide DiPEA N,N-diisopropylethylamine DMAP 4-dimethylaminopyridine DMF N,N-dimethylformamide DMSO dimethylsulfoxide DNA deoxyribonucleic acid DOSPER
1,3-dioleyloxy-2-(6-carboxy-spermidyl)propylamide DPPA diphenylphosphoryl azide DPX dansylated polymyxin B DRC (S7T)-drosocin DTT dithiothreitol EDC N-(3-dimethylaminopropyl)-NĻ-ethylcarbodiimide EDTA ethylenediaminetetraacetate ESI electrospray interface
Et ethyl
eq. equivalent(s)
E-gel gel containing ethylene glycol F (prefix) fluorous
FA or fa fatty acyl
FDA (United States) Federal Drug Administration
FITC fluoresceinyl isothiocyanate Fmoc 9-fluorenylmethoxycarbonyl Gal galactose G_ Gram-negative G+ Gram-positive Glc glucose Gln (Q) glutamine Glu (E) glutamic acid Gly (G) glycine
List of Abbreviations
7
G-gel gel containing glycerol HATU O-(7-azabenzotriazol-1-yl)-N,N,NĻ,NĻ-tetramethyluronium hexafluorophosphate hBD human ǃ-defensin HCTU O-(6-chlorobenzotriazol-1-yl)-N,N,NĻ,NĻ-tetramethyluronium hexafluorophosphate
Hep L-glycero-D-manno-heptose HEPES N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) His (H) histidine HMDS hexamethyldisilazane HOAt 1-hydroxy-7-azabenzotriazole HOBt 1-hydroxybenzotriazole HPLC high-performance liquid chromatography HRMS high-resolution mass spectrometry HSer (ǃS) ǃ3-homoserine HTyr (ǃY) ǃ3-homotyrosine
IBX triacetoxyiodobenzoic acid IL interleukin
Ile (I) isoleucine
IM inner (cytoplasmic) membrane IR infrared
ISB iso-sensitest broth
ISO International Organization for Standardization
ivDde 1-(4,4-dimethyl-2,6-dioxocyclo- hex-1-ylidene)-3-methylbutyl Kdo 3-deoxy-D
-manno-oct-2-ulosonic acid KFF KFF peptide (KFF)3K LB Luria-Bertani (broth) LBP LPS-binding protein LC liquid chromatography LCMS liquid chromatography/mass spectrometry Leu (L) leucine LPS lipopolysaccharide Lys (K) lysine OM outer membrane Orn (O) ornithine
Mamb m-(aminomethyl)benzoic acid MALDI matrix-assisted laser
desorption/ionisation Me methyl MeArg (MeR) Nǂ-methylarginine MeSer (MeS) N-methylserine Met (M) methionine MHC minimal hemolytic concentration
MIC minimal inhibitory
concentration, i.e. the lowest concentration at which no bacterial growth can be detected by spectroscopic analysis after incubation for a specified time, compared with a positive control (Triton X-100).
MIM N-methyl-N’-alkyl imidazolium
MMT (4-methoxytriphenyl)methyl MOA (S)-6-methyloctanoyl, -oic acid Mpa 3-maleimidopropionyl MPD
N-methyl-N-alkyl-pyrrolidinium MS mass spectrometry MS/MS tandem mass spectrometry Msc methylsulfonylethoxycarbonyl Mtt (4-methyltriphenyl)methyl MW microwave (oven) n (prefix) natural
n- normal (linear) n/a not applicable n/d not determined NBE nutrient broth E NCL native chemical ligation nG not glycosylated NMP N-methylpyrrolidone NMR nuclear magnetic resonance NOE nuclear Overhauser effect NOESY nuclear Overhauser effect
spectroscopy Orn (O) ornithine
Pamb p-(aminomethyl)benzoic acid PAMP pathogen-associated molecular
List of Abbreviations
8
PyBroP bromotripyrrolidino- phosphonium hexafluorophosphate QAC quaternary ammonium
compound RBC red blood cell Ref. reference Rf retardation factor
RNA ribonucleic acid ROESY rotating frame NOESY RP reversed phase Rt retention time RT room temperature RTD rhesus lj-defensin s (prefix) synthetic
SAA sugar amino acid Sar sarcosine sat. saturated
SCL 3-carboxypropanesulfonamide Ser (S) serine
SIC streptococcal inhibitor of complement
SPE solid-phase extraction SPPS solid-phase peptide synthesis SPy 2-pyridylsulfenyl
SS disulfide linkage StBu tert.butylsulfenyl Su succinimidyl tBu tert.butyl
TCA trichloroacetic acid
TCEP tris(carboxyethyl)phoshine TES triethylsilane
TFA trifluoroacetic acid TFE 2,2,2-trifluoroethanol THF tetrahydrofuran THP tetrahydropyran Thr (T) threonine TIC total ion count TIS triisopropylsilane Tmd 3-(trifluoromethyl)-3H-diazirin-3-yl TMS trimethylsilyl TNBS 2,4,6-trinitrobenzenesulfonic acid
TNF tumor necrosis factor TLC thin-layer chromatography TLR Toll-like receptor
TOCSY total correlation spectroscopy TOF time-of-flight
Tr triphenylmethyl Tran tranexamic acid Trp (W) tryptophane TTC tritrpticin Tyr (Y) tyrosine
UDP uridine 5’-diphosphate UV ultraviolet
Val (V) valine